“Reiterates 'Add' rating on TCS with a target price of ₹2,600, implying a nearly 27% upside. Despite a soft Q1 performance, growth is expected to improve, driven by recovery in Life Sciences and Manufacturing verticals, alongside continued strength in Technology Services and BFSI. Valuations remain attractive, but the brokerage awaits further clarity.”